Latest InspireMD Inc. Stories
MASTER I and MASTER II Pooled Data Show Statistically Significant Mortality Benefit BOSTON, Dec.
Master II 30 day data to be presented December 15th at the ICI Meeting 2014, Tel-Aviv BOSTON, Nov.
Validation of manufacturing process changes for the MGuard Prime EPS BOSTON, Oct.
MGuard Prime commercial re-launch complete in direct markets BOSTON, Oct.
Commercial activities ahead of schedule following release of strong clinical data in the multi-specialty CARENET trial BOSTON, Oct.
CARENET Trial data presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, September 16, 2014, showed 0% MACE at 30 Days BOSTON, Sept.
- a meat pie that is usually eaten at Christmas in Quebec